Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 53
Appendix A Workshop Agenda Changing Prescription Medication Use Container Instructions to Improve Health Literacy and Medication Safety October 12, 2007 8:30 a.m. – 5:30 p.m. Room 100 Keck Center of the National Academies 500 Fifth Street, NW Washington, DC 20001 8:30 – 8:40 Welcome and Opening Remarks Moderator: George Isham, M.D., M.S. Chair, Institute of Medicine Roundtable on Health Literacy Medical Director and Chief Health Officer HealthPartners 8:40 – 9:00 Drug Safety in Ambulatory Care—Where Is the Patient? Dan Budnitz, M.D., M.P.H. Medical Officer Division of Healthcare Quality Promotion Coordinating Center for Infectious Diseases, CDC 9:00 – 9:15 To Err Is Human: The Role of Health Literacy in Patient Care Terry C. Davis, Ph.D. Professor of Medicine and Pediatrics Louisiana State University Health Sciences Center 53
OCR for page 53
54 Standardizing medication labels 9:15 – 9:45 Findings of the ACP Foundation White Paper on Drug Labeling Michael Wolf, Ph.D., M.P.H. Assistant Professor of Preventive Medicine Feinberg School of Medicine, Northwestern University 9:45 – 10:00 Discussion of Morning Presentations 10:00 – 10:30 Simplification of Drug Dosing Times: Can We Confuse Patients Less? A Proposal for Standardization Alastair J. J. Wood, M.D., F.A.C.P. Managing Director Symphony Capital LLC 10:30 – 11:30 Panel I: Federal Agency Reaction to Prescription Use Instruction Standardization Cindy Brach, M.P.P. Senior Health Policy Researcher Agency for Healthcare Research and Quality Nancy Ostrove, Ph.D. Senior Advisor for Risk Communication, Office of Planning, Office of the Commissioner, Food and Drug Administration Virginia Torrise, Pharm.D. Deputy Chief Consultant for Pharmacy Benefits Management Department of Veterans Affairs 11:30 – 12:45 Panel II: Pharmacy Reaction to Prescription Use Instruction Standardization Alan Goldhammer, Ph.D. Deputy Vice President, Regulatory Affairs PhRMA Darren K. Townzen, R.Ph., M.B.A. Director of Pharmacy Systems Wal-Mart Gerald McEvoy, Pharm.D. Assistant Vice President of Drug Information American Society of Health-System Pharmacists William Ellis, R.Ph., M.S. Chief Executive Officer American Pharmacists Association Foundation 12:45 – 1:30 Lunch Break
OCR for page 53
APPENDIX A 55 1:30 – 2:40 Panel IIIa: Other Stakeholder Reaction to Prescription Use Instruction Standardization: Physicians and Patients William Dolan, M.D. Board Member American Medical Association Albert Wu, M.D., M.P.H. Professor of Health Policy and Management Bloomberg School of Public Health, Johns Hopkins University William Bullman, M.A.M. Executive Vice President National Council on Patient Information and Education Linda Weiss, Ph.D. Researcher Center for Urban Epidemiologic Studies New York Academy of Medicine Mara Youdelman, J.D., L.L.M. Staff Attorney National Health Law Program 2:40 – 3:10 Panel IIIb: Other Stakeholder Reaction to Prescription Use Instruction Standardization: Educators of Pharmacists and Physicians Mary Ann F. Kirkpatrick, Ph.D. Associate Dean for Student Affairs Shenandoah University Bernard J. Dunn School of Pharmacy American Association of Colleges of Pharmacy Merrill Egorin, M.D. Professor of Medicine and Pharmacology University of Pittsburgh School of Medicine Co-Director, Molecular Therapeutics/Drug Discovery Program University of Pittsburgh Cancer Institute AAMC, Expert Panel on Education in Safe and Effective Prescribing Practices 3:10 – 3:30 Break 3:30 – 4:45 Panel IV: What Would It Take to Move Toward Prescription Use Instruction Standardization? Roger Williams, M.D. Executive Vice President Chief Executive Officer United States Pharmacopeia Darren K. Townzen, R.Ph., M.B.A. Director of Pharmacy Systems Wal-Mart National Council for Prescription Drug Programs, Inc. Susan Johnson, Pharm.D., Ph.D. Associate Director of the Office of Nonprescription Products Food and Drug Administration Vanessa Cajina, M.P.A. Regional Networks Coordinator Latino Coalition for a Healthy California
OCR for page 53
56 Standardizing medication labels 4:45 – 5:30 Summary and Discussion Closng Remarks Ruth Parker, M.D. Associate Professor of Medicine, Emory University